Salva Reverentia Yurista completed his medical degree in Indonesia and he is an active practitioner in preventive cardiology with a particular interest in lipid risk factor in Indonesia. Dr. Yurista has participated in a variety of national committees. He is currently doing research in pleiotropic protective effects of cardiovascular drugs to prevent cardiac remodeling at University Medical Center Groningen, The Netherlands. He is a secretary of Malang Molecular Biology Institute and actively participates in numerous events of Indonesian Heart Foundation. He is also member of Working Group on Atherosclerosis and Vascular Biology and Working Group on Cardiovascular Pharmacotherapy of European Society of Cardiology.